Literature DB >> 15614580

Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene.

Shoichi Sasaki1, Hitoshi Warita, Tetsuro Murakami, Noriyuki Shibata, Takashi Komori, Koji Abe, Makio Kobayashi, Makoto Iwata.   

Abstract

The ultrastructural features of SOD1-positive aggregates were determined to clarify whether these aggregates are associated with the pathogenesis of SOD1 mutant mice. We examined the spinal cord of transgenic mice expressing a G93A mutant human SOD1 gene with fewer copies (gene copy 10). At the early presymptomatic stage (age 24 weeks), SOD1- and ubiquitin-positive granular, linear, or round deposits were found occasionally in the neuropil of the anterior horns. Ultrastructurally, small filamentous aggregates were observed occasionally in the neuronal processes including the axons in the anterior horns. At the late presymptomatic stage (28 weeks), SOD1- and ubiquitin-positive deposits and Lewy body-like inclusions (LIs) were frequently demonstrated in the neuronal processes including cord-like swollen axons and in some remaining anterior horn neurons. Ultrastructurally, larger filamentous aggregates were frequent, predominating in the neuronal processes of the anterior horns including the proximal axons, but were rare in the somata and dendrites. The aggregates usually consisted of interwoven intermediate filaments (about 10-15 nm in diameter) and frequently contained electron-dense cores in the center resembling LIs. Occasionally the aggregates consisted mainly of granular, amorphous, or vesicular substance, showing fewer filamentous structures. At the symptomatic stages (32 and 35 weeks), LIs were frequently demonstrated within the neuronal processes in the anterior horns, particularly in the cord-like swollen axons. Many more prominent SOD1- and ubiquitin-positive deposits were observed over the whole white matter columns and in the gray matter of the anterior and posterior horns than at the previous stage. Ultrastructurally, aggregates frequently contained electron-dense cores, and were frequently observed in cord-like swollen axons consisting of accumulated neurofilaments. A high level of human SOD1-and ubiquitin-immunogold labeling was present in small to large aggregates even at the presymptomatic stages, and the aggregates increased in size and frequency with time. Compactly packed filaments and electron-dense cores of aggregates showed SOD1-and ubiquitin-immunogold labeling more prominently than in loosely packed filaments. These findings suggest that the accumulation of SOD1-positive aggregates in the neuronal processes, predominantly in the axons, constitutes an important determinant of neurotoxicity and the pathogenesis of this animal model, probably causing impairment of axonal transport by the sequestration of mutant SOD1 protein within aggregates, or in part by physically blocking the axonal transport.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614580     DOI: 10.1007/s00401-004-0939-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice.

Authors:  Yuxiang Xie; Bing Zhou; Mei-Yao Lin; Shiwei Wang; Kevin D Foust; Zu-Hang Sheng
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

2.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Authors:  Ashley J Pratt; David S Shin; Gregory E Merz; Robert P Rambo; W Andrew Lancaster; Kevin N Dyer; Peter P Borbat; Farris L Poole; Michael W W Adams; Jack H Freed; Brian R Crane; John A Tainer; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

3.  The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitro.

Authors:  Justin J Yerbury; Dane Gower; Laura Vanags; Kate Roberts; Jodi A Lee; Heath Ecroyd
Journal:  Cell Stress Chaperones       Date:  2012-09-21       Impact factor: 3.667

Review 4.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

5.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

6.  IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.

Authors:  Milan Fiala; Madhuri Chattopadhay; Antonio La Cava; Eric Tse; Guanghao Liu; Elaine Lourenco; Ascia Eskin; Philip T Liu; Larry Magpantay; Stephen Tse; Michelle Mahanian; Rachel Weitzman; Jason Tong; Caroline Nguyen; Tiffany Cho; Patrick Koo; James Sayre; Otoniel Martinez-Maza; Mark J Rosenthal; Martina Wiedau-Pazos
Journal:  J Neuroinflammation       Date:  2010-11-09       Impact factor: 8.322

Review 7.  Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.

Authors:  Madhuri Chattopadhyay; Joan Selverstone Valentine
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

8.  Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)?

Authors:  Sónia S Leal; Isabel Cardoso; Joan S Valentine; Cláudio M Gomes
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

Review 9.  Mitochondria: a therapeutic target in neurodegeneration.

Authors:  Paula I Moreira; Xiongwei Zhu; Xinglong Wang; Hyoung-Gon Lee; Akihiko Nunomura; Robert B Petersen; George Perry; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2009-10-21

10.  Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.

Authors:  Zeynep A Oztug Durer; Jeffrey A Cohlberg; Phong Dinh; Shelby Padua; Krista Ehrenclou; Sean Downes; James K Tan; Yoko Nakano; Christopher J Bowman; Jessica L Hoskins; Chuhee Kwon; Andrew Z Mason; Jorge A Rodriguez; Peter A Doucette; Bryan F Shaw; Joan Selverstone Valentine
Journal:  PLoS One       Date:  2009-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.